Ballicules.com

Metaxalone

SKELAXIN

What it isCentral muscle relaxant of uncertain mechanism; acute musculoskeletal spasm.

Why this oneIt impairs alertness less than many skeletal muscle relaxants, but direct evidence of benefit is unusually thin.

What limits itFood raises exposure, and alcohol or opioids amplify sedation; rare hemolytic anemia and hepatotoxicity occur.

FDA-approved for

FDA label

FDA dosingPopulationStartTargetMax
Acute painful musculoskeletal conditions (adjunct)Adults & children >12 yr800 mg TID–QID800 mg TID–QID3200 mg/day

Renal Contraindicated in significantly impaired renal function

Hepatic Contraindicated in significantly impaired hepatic function

Contraindications

Cautions

Adverse reactions

Pregnancy Safe use not established; should not be used in women who are or may become pregnant, particularly in early pregnancy, unless benefit outweighs hazard

Lactation Undefined

NO BOXED WARNINGS

Principal riskWeak efficacy evidence; take with food

Cost, est. cash$10–$300/month

Generic entry2010

Classes and tags

Clinical profile

Therapeutic safety burden1 / 4
Overdose danger1 / 4
Weight-gain liability0 / 4
Sedation liability2 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk1 / 4

Legacy pregnancy categoryUnknown / historical label unavailable

Defining liabilityGenerally tolerated at therapeutic doses; clinically important risks are agent-specific and increase with interactions or organ impairment.

Mechanism of action: Metaxalone ballicule

Metaxalone ballicule: receptor binding, kinetics and half-life diagram

Open Metaxalone in the interactive console ↗

Memory aids: mascots and interaction avatars

Metaxalone SKELAXIN mascot mnemonic cartoon
“Skeletor Relaxin’ (with a) Meat ax, alone”
Mao Zedong → monoamine oxidase (MAO) inhibitor
Metaxalone Box: minimal PK interactions avatar
Box: minimal PK interactions

Open Metaxalone in the interactive console ↗